The cGAS-STING pathway in ischemia-reperfusion injury in acute cerebral infarction: a new therapeutic opportunities? DOI Creative Commons
Jun Hu,

Mengxiang Tian

Frontiers in Neurology, Journal Year: 2024, Volume and Issue: 15

Published: Dec. 17, 2024

The innate immune response is the body's first line of defense against external pathogens and endogenous damage signals. cGAS-STING pathway a crucial component response, playing key role in initiating antiviral anti-infective responses by recognizing cytosolic DNA. Acute cerebral infarction one leading causes death disability worldwide, with primary treatment approach being restoration blood flow to ischemic brain tissue. However, reperfusion injury remains significant challenge during treatment. overactivation its association ischemia-reperfusion have been confirmed numerous studies. This article will systematically elucidate mechanisms pathway, acute infarction, current research status inhibitors, application nanomaterials this context, evaluating therapeutic potential pathway.

Language: Английский

Nanotechnology’s frontier in combatting infectious and inflammatory diseases: prevention and treatment DOI Creative Commons
Yujing Huang, Xiaohan Guo, Yi Wu

et al.

Signal Transduction and Targeted Therapy, Journal Year: 2024, Volume and Issue: 9(1)

Published: Feb. 21, 2024

Abstract Inflammation-associated diseases encompass a range of infectious and non-infectious inflammatory diseases, which continuously pose one the most serious threats to human health, attributed factors such as emergence new pathogens, increasing drug resistance, changes in living environments lifestyles, aging population. Despite rapid advancements mechanistic research development for these current treatments often have limited efficacy notable side effects, necessitating more effective targeted anti-inflammatory therapies. In recent years, nanotechnology has provided crucial technological support prevention, treatment, detection inflammation-associated diseases. Various types nanoparticles (NPs) play significant roles, serving vaccine vehicles enhance immunogenicity carriers improve targeting bioavailability. NPs can also directly combat pathogens inflammation. addition, facilitated biosensors pathogen imaging techniques This review categorizes characterizes different NPs, summarizes their applications It discusses challenges associated with clinical translation this field explores latest developments prospects. conclusion, opens up possibilities comprehensive management

Language: Английский

Citations

147

Advances in nanomaterial-targeted treatment of acute lung injury after burns DOI Creative Commons
Shuo Zhang, Xinyu Zhao,

Yuhao Xue

et al.

Journal of Nanobiotechnology, Journal Year: 2024, Volume and Issue: 22(1)

Published: June 18, 2024

Abstract Acute lung injury ( ALI ) is a common complication in patients with severe burns and has complex pathogenesis high morbidity mortality rates. A variety of drugs have been identified the clinic for treatment ALI, but they toxic side effects caused by easy degradation body distribution throughout body. In recent years, as understanding mechanism underlying improved, scholars developed new nanomaterials that can be safely effectively targeted ALI. Most these methods involve such lipids, organic polymers, peptides, extracellular vesicles or cell membranes, inorganic nanoparticles other nanomaterials, which are to reach tissues perform their functions through active targeting passive targeting, process involves cells organelles. this review, first, mechanisms pathophysiological features occurrence after burn reviewed, potential therapeutic targets summarized, existing classified, possible problems challenges discussed provide reference development

Language: Английский

Citations

11

Targeting tumor-associated macrophages with mannosylated nanotherapeutics delivering TLR7/8 agonist enhances cancer immunotherapy DOI

Bao-Toan Nguyen Dang,

Ramesh Duwa, Sooyeun Lee

et al.

Journal of Controlled Release, Journal Year: 2024, Volume and Issue: 372, P. 587 - 608

Published: June 29, 2024

Language: Английский

Citations

7

The Role of the Nuclear Factor-Kappa B (NF-κB) Pathway in SARS-CoV-2 Infection DOI Creative Commons
Periyanaina Kesika,

Subramanian Thangaleela,

S. Natarajan

et al.

Pathogens, Journal Year: 2024, Volume and Issue: 13(2), P. 164 - 164

Published: Feb. 12, 2024

COVID-19 is a global health threat caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and associated with significant increase in morbidity mortality. The present review discusses nuclear factor-kappa B (NF-κB) activation its potential therapeutical role treating COVID-19. pathogenesis, the major NF-κB pathways, involvement of SARS-CoV-2 have been detailed. Specifically, impact on managing has discussed. As central player immune inflammatory responses, modulating could offer strategic avenue for infection. Understanding pathway’s aid developing treatments against SARS-CoV-2. Further investigations into intricacies are required to reveal effective therapeutic strategies combating infection

Language: Английский

Citations

6

Renal Clearable Nanodots‐Engineered Erythrocytes with Enhanced Circulation and Tumor Accumulation for Photothermal Therapy of Hepatocellular Carcinoma DOI
Quanxiao Li, Meng Jin, Zhen Ding

et al.

Small, Journal Year: 2024, Volume and Issue: 20(25)

Published: Jan. 9, 2024

Abstract Living cell‐mediated nanodelivery system is considered a promising candidate for targeted antitumor therapy; however, their use restricted by the adverse interactions between carrier cells and nanocargos. Herein, novel erythrocyte‐based developed assembling renal‐clearable copper sulfide (CuS) nanodots on outer membranes of erythrocytes via lipid fusion approach, demonstrate that it an efficient photothermal platform against hepatocellular carcinoma. After intravenous injection system, CuS assembled can be released from accumulate in tumors response to high shear stress bloodstream, show excellent effect under near infrared laser irradiation. Therefore, erythrocyte‐mediated holds many advantages including prolonged blood circulation duration enhanced tumor accumulation. Significantly, elimination half‐life 74.75 ± 8.77 h, which much longer than (33.56 2.36 h). Moreover, other two kinds well onto produce hitchhiking platforms. Together, findings promote not only development systems as potential platforms treatment but also further clinical translation toward personalized healthcare.

Language: Английский

Citations

5

PTPRT loss enhances anti–PD-1 therapy efficacy by regulation of STING pathway in non–small cell lung cancer DOI
Zhuo Chen, Wenxiang Ji,

Wenxin Feng

et al.

Science Translational Medicine, Journal Year: 2024, Volume and Issue: 16(763)

Published: Sept. 4, 2024

With the revolutionary progress of immune checkpoint inhibitors (ICIs) in non–small cell lung cancer, identifying patients with cancer who would benefit from ICIs has become critical and urgent. Here, we report protein tyrosine phosphatase receptor type T (PTPRT) loss as a precise convenient predictive marker independent PD-L1 expression for anti–PD-1/PD-L1 axis therapy. Anti–PD-1/PD-L1 treatment markedly increased progression-free survival PTPRT-deficient tumors. tumors displayed cumulative DNA damage, cytosolic release, higher tumor mutation burden. Moreover, residue 240 STING was identified direct substrate PTPRT. PTPRT elevated phosphorylation at Y240 thus inhibited its proteasome-mediated degradation. released more IFN-β, CCL5, CXCL10 by activation pathway infiltration, especially CD8 cells natural killer cells, ultimately enhancing efficacy anti–PD-1 therapy multiple subcutaneous orthotopic mouse models. The response to depends on tumor-intrinsic pathway. In summary, our findings reveal mechanism how sensitive highlight biological function innate immunity. Considering prevalence mutations negative expression, this study great value patient stratification clinical decision-making.

Language: Английский

Citations

5

Innate immunity-modulating nanobiomaterials for controlling inflammation resolution DOI
Yongjiang Li, Wei Chen, Seyoung Koo

et al.

Matter, Journal Year: 2024, Volume and Issue: 7(11), P. 3811 - 3844

Published: Nov. 1, 2024

Language: Английский

Citations

4

Bioengineered NanoAid synergistically targets inflammatory pro-tumor processes to advance glioblastoma chemotherapy DOI
Zhang Gui, Yurui Xu, Anwei Zhou

et al.

Nanoscale, Journal Year: 2025, Volume and Issue: unknown

Published: Jan. 1, 2025

Through transcriptomic analysis of glioblastoma tissues from patients, we developed a combined formulation (NanoAid) for improving glioma synergistic chemotherapy.

Language: Английский

Citations

0

Ethyl Caffeate Alleviates Inflammatory Response and Promotes Recovery in Septic-Acute Lung Injury via the TNF-α/NF-κB/MMP9 Axis DOI

Yuan‐Lan Huang,

Gang Li, Dan Li

et al.

Phytomedicine, Journal Year: 2025, Volume and Issue: unknown, P. 156700 - 156700

Published: March 1, 2025

Language: Английский

Citations

0

Biocompatible and Size-Dependent Melanin-Like Nanocapsules for Efficient Therapy in Hyperoxia-Induced Acute Lung Injury DOI

Yong Sheng Han,

Jie Dong, Liyan Zhang

et al.

Biomaterials, Journal Year: 2025, Volume and Issue: 318, P. 123169 - 123169

Published: Feb. 5, 2025

Language: Английский

Citations

0